Abnormal Fibrous Blood Clots Reported Worldwide
By mid-2021, embalmers worldwide pulled from dead bodies odd, white or brown fibrous clots. The embalmers reported that they had never before seen such matter.An embalmer is a highly trained professional with a specialized skill set, who works in a funeral home, laboratory, or research facility; he or she is responsible for preparing the bodies of the deceased for funeral services.
Their daily work is to replace blood with embalming fluid in the blood vessels. Since the middle of 2021, an increasing number of embalmers have been talking about their inability to replace blood with embalming fluid in some dead bodies.
Seeking to discover the cause of this, the embalmers we interviewed and those featured in a video series on the topic looked for what was blocking the veins and arteries.
Distinctive Fibrous Clots Caused by Vaccine
The “clots” featured in these interviews with embalmers do not look like normal blood clots. They present the following distinctive features:- Color. They are often white or brown, while normal blood clots are very dark red to black.
- Size and shape. They are string-like shapes a few inches to several feet long. Traditional blood clots are generally irregular, flat, and clump-like.
- Nature. They are rubbery and firm, while traditional blood clots are usually soft.
- Location. They are in veins and arteries, while traditional blood clots are typically found in veins.
If COVID caused these strange fibrous clots, someone would have spotted them before 2021, but nothing of the sort was reported in 2020.
Numerous embalmers have stated that they began to see these clots in 2021, coinciding with the vaccine rollout—not in 2020, which coincided with the beginning of the pandemic—giving us some insight into the origin of these fibrous clots.
As of January 2022, Omicron had taken over as the dominant COVID variant across the United States. Omicron infection is associated with a much lower mortality rate than COVID-19. Therefore, if these unusual clots were COVID-19-related, the instances of finding them should have lessened in January 2022.
However, based on embalmers’ reports, the rates of these strange clots increased in 2022.
According to these analyses, the causal role of COVID vaccination in forming these abnormal clots is very likely.
What are the main differences between the natural infection-derived clots and the vaccination-associated clots if spike protein contributes to both types?
1. Spike Protein Alone Can Form Clots in Plasma
Thrombin is an essential protein that forms typical blood clots. Thrombin clots blood by activating platelets and chopping up a protein called fibrinogen to form fibrin, a blood clot component.However, people may not be aware that spike protein alone can form blood clots even without normal blood clot components.
If we compare graphs B and D, as long as spike protein was added to platelet-poor plasma (PPP), with (graph D) or without (graph B) thrombin, a similar significant increase in dense anomalous clotted deposits was noted.
When healthy PPP was exposed to spike protein only, there was a considerable increase in anomalous clots (graph B).
This is of particular interest as it demonstrates that spike protein alone, even without thrombin, can form fibrous-like clots.

(A) PPP smear. (B) PPP with spike protein. (C) PPP with thrombin to create extensive fibrin clots. (D) PPP exposed to spike protein followed by the addition of thrombin. The final spike protein concentration was 1 ng.ml−1.
(Image from Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep. 2021 Aug 27;41(8):BSR20210611. doi: 10.1042/BSR20210611. )
2. Spike Protein Has Amyloidogenic Structure and Binds With Amyloid Proteins
Based on the analysis conducted by Mike Adams, journalist and science lab director, of clots supplied by Richard Hirschman, these strange white or brownish clots are not typical blood clots. In fact, they are primarily amyloid proteins.Their structures make it easy to form tighter string-like bonded structures with longitudinal twisting as well as cross-binding, forming a fibrous-like structure.
An analogy of this process is making hemp rope: short and slim hemp fibers can be rolled into long, strong ropes with high force resistance.

Using an analogy to explain this phenomenon—that the spike protein alone could form amyloid aggregates and combine with other amyloids—it’s similar to a little seed crystal dropped into a solution: a large crystal will grow bigger and bigger over time.
So it’s no surprise to see a lengthy fibrous clot structure forming after COVID vaccination.
Those lengthy clots were reported mainly after mid-2021, about six months after the vaccines became widely available.
3. Spike Proteins Originated From the Vaccine Are More Stable Than Virus’ Spike
The spike produced by the COVID vaccine is not the same as the virus’ natural spike.The natural spike protein from SARS-CoV-2 is unstable and easier to degrade, which is one reason that the COVID natural infection itself may not have generated excessive stable spike protein or many unusual blood clots before the vaccine rollout.
The natural spike instability was initially a critical bottleneck for the vaccine’s development.
Accordingly, scientists modified the natural spike protein’s structure to result in a more stabilized form of the spike after mRNA vaccination; the goal was to achieve a higher level of antibodies.
After this proline insertion, the higher amount of pre-fusion-stabilized spike proteins in vaccinated persons—versus the amount in naturally infected people—helps explain the lengthy clots in vaccinated people.
4. Amount of Spike Protein in Vaccinated People Is Confirmed to Be Higher Than Natural Infection
Following mRNA vaccination, the mRNA vaccine’s endogenously produced S protein concentration is much higher than in natural infection.Circulating S1 subunits were detected in most COVID-19 patients, possibly as a result of viral antigen leakage into the blood in subjects with severe disease.
Only some vaccinated people have AEs. But those vaccinated who have experienced AEs are likely to have a higher level of spike proteins in their body, dependent on genetic and epigenetic predisposition factors, including lifestyle.
5. Virus Weakened but Vaccines Still Based on Original Virus’ Spike
Current Omicron strains have much-weakened toxicity, as the spike protein in Omicron has mutated and does not have all the abilities of clotting or dysregulating immune response. However, the COVID vaccines are still made based on the original Wuhan strain and are causing many clotting problems.6. Spike Protein’s Key Role in the Blood Clotting Cascade
Normal blood clots can occur in vaccinated people. But spike protein can trigger the clotting cascade via inducing endothelial disruption, inflammation of endothelial cells, “life-threatening thrombotic complications,” hyperactivating platelets via multiple receptors (ACE2, TMPRSS2, or fibronectin receptor), fibrous network from neutrophil extracellular traps (NETs), as well as increasing angiotensin II level, activating Toll-like receptor 4, and increasing coagulation factor (FXa) production, all adding up to activate blood clotting “cascades.”Spike protein causes damage to the endothelial layers of the blood vessels, then a clotting cascade follows, and then fibrin forms.


Monitor Blood Clot-Related Adverse Events After mRNA Jab
The JAMA Network analyzed the US Kaiser Permanente Vaccine Study Center surveillance data on 6.2 million people (mean age, 49 years; 54 percent female individuals) who received 11.8 million doses of an mRNA vaccine (57 percent BNT162b2; 6.17 million first doses and 5.67 million second doses).Table 1: Serious Adverse Events Reported After mRNA Vaccines by JAMA
Number | Serious Adverse Events | 1-21 days after vaccination |
Treatment Strategies for Vaccine-Induced Unusual Clots
It has been reported that “suitable and closely monitored ‘triple’ anticoagulant therapy leads to the removal of the microclots.” “Triple” anticoagulant therapy normally includes an oral anticoagulant plus two drugs designed to decrease platelet activation.Anticoagulants are one of two (along with antiplatelet) classes of antithrombotic drugs, also called blood thinning drugs or blood thinners. Anticoagulants act on the clotting cascade and keep it from completion.
Because of the difference in the components of vaccine-induced clots versus normal blood clots, blood-thinning drugs may not work in vaccinated people.
1. Targeted Therapies
Insights could be gained from the treatment of amyloidosis, including the use of monoclonal antibodies.2. Nutraceuticals Effective in Reducing Amyloid
Amyloid is a type of misfolded protein, and it is this misfolding that shapes lengthy fibers. If we can correct the protein misfolding process, that could inhibit the development of long fibers.Natural compounds may emerge as promising, new therapeutic approaches to intervening in protein-misfolding processes.
EGCG promotes the formation of stable, spherical aggregates, which are not toxic to living cells.
The following compounds reduce amyloid-related burdens in animal models. They may help reduce COVID vaccine-caused formation of amyloid-like fibrous clots.
3. Meditation May Reduce Amyloid
A study published in Translational Psychiatry in 2016 followed 64 healthy women, half of whom were given a vacation, while the other half meditated.Summary
Research on COVID vaccines is mostly limited to serological analysis—antibodies produced after injection.However, beyond the analysis of immune responses, understanding the safety profile of those vaccines in humans is mandatory to ensure their safety, maintain a trusted health system, and protect public safety.
Multiple lines of preclinical evidence and clinical observations as a whole support a causal link between the spike protein-based COVID-19 vaccine and reported abnormal white or brown fibrous clots.
These abnormal clots block the blood vessels and cause significant clinical outcomes, including heart attack, stroke, and pulmonary embolism, which could contribute to the reported sudden death cases in vaccinated people.
There are still unknowns in the pathogenesis of these clots. However, avoiding the vaccine and promoting autophagy to clear the toxic protein from our bodies is certainly the top priority.
It is recommended to carefully monitor post-vaccination symptoms as they indicate potentially existing blood clots. Always consult your physician whenever you feel ill.